SRC and IGF-1R are reciprocally co-activated in high levels in non-small cell lung cancer (NSCLC) cells and inhibition of IGF-1R resulted in activation of SRC, and targeting SRC resensitzed cells to IGF-1R inhibition [46]. The gene discussed is IGF1R; the disease is non-small cell lung carcinoma.